Inflammatory Risk in Statin-Treated Patients


Episode Artwork
1.0x
0% played 00:00 00:00
Dec 10 2024 11 mins  
Pooling data from the PROMINENT, REDUCE-IT, and STRENGTH trials, Paul Ridker and C. Michael Gibson discuss the residual inflammatory risks for patients treated with statins.